首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1619646篇
  免费   147692篇
  国内免费   2621篇
耳鼻咽喉   23312篇
儿科学   56044篇
妇产科学   41743篇
基础医学   234716篇
口腔科学   46394篇
临床医学   142840篇
内科学   339489篇
皮肤病学   41341篇
神经病学   135628篇
特种医学   60624篇
外国民族医学   716篇
外科学   242898篇
综合类   28410篇
现状与发展   1篇
一般理论   481篇
预防医学   125490篇
眼科学   34666篇
药学   119361篇
  2篇
中国医学   4383篇
肿瘤学   91420篇
  2021年   14698篇
  2020年   12664篇
  2019年   24403篇
  2018年   30178篇
  2017年   24721篇
  2016年   26351篇
  2015年   28563篇
  2014年   34453篇
  2013年   47983篇
  2012年   59843篇
  2011年   62102篇
  2010年   40476篇
  2009年   34350篇
  2008年   55765篇
  2007年   58655篇
  2006年   57430篇
  2005年   56049篇
  2004年   53732篇
  2003年   51406篇
  2002年   49829篇
  2001年   70467篇
  2000年   73334篇
  1999年   61930篇
  1998年   16452篇
  1997年   14805篇
  1996年   15134篇
  1995年   14314篇
  1994年   13477篇
  1993年   12407篇
  1992年   47477篇
  1991年   46093篇
  1990年   44624篇
  1989年   42236篇
  1988年   38874篇
  1987年   38107篇
  1986年   35416篇
  1985年   33951篇
  1984年   25385篇
  1983年   21328篇
  1982年   12372篇
  1979年   22452篇
  1978年   15612篇
  1977年   13257篇
  1976年   12333篇
  1975年   13436篇
  1974年   15625篇
  1973年   15122篇
  1972年   13856篇
  1971年   12599篇
  1970年   11876篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
21.
Gold nanoparticles (Au NPs) hold great promise in food, industrial and biomedical applications due to their unique physicochemical properties. However, influences of the gastrointestinal tract (GIT), a likely route for Au NPs administration, on the physicochemical properties of Au NPs has been rarely evaluated. Here, we investigated the influence of GIT fluids on the physicochemical properties of Au NPs (5, 50, and 100?nm) and their implications on intestinal epithelial permeability in vitro. Au NPs aggregated in fasted gastric fluids and generated hydroxyl radicals in the presence of H2O2. Cell studies showed that GIT fluids incubation of Au NPs affected the cellular uptake of Au NPs but did not induce cytotoxicity or disturb the intestinal epithelial permeability.  相似文献   
22.
Adjuvant irradiation is the standard treatment after breast conservative surgery. Normofractionated regimen with an overall treatment time of 5 to 6 weeks is often considered as a limiting factor for irradiation compliance. In order to answer this issue, moderate and more recently extreme hypofractionated protocols appeared. We report here oncological outcomes and toxicity of hypofractionated breast irradiation. After defining the frame of moderate and extreme hypofractionated breast irradiations based on overall treatment time, patient selection criteria were listed. According to their levels of proof, the results of moderate and extreme hypofractionated breast irradiation were analysed. Overall treatment time for moderate hypofractionated breast irradiation ranged from 3 to 4 weeks, while for extreme hypofractionated breast irradiation, it was less than 1 week. For moderate hypofractionated breast irradiation, whole breast irradiation was currently performed with or without lymph node irradiation. Moderate hypofractionated breast irradiation has proven to be as safe and as efficient as normofractionated breast irradiation with level IA evidence. For extreme hypofractionated breast irradiation, phase III randomized trials confirmed that accelerated partial breast irradiation was non-inferior in terms of local control compared to normofractionated whole breast irradiation (with external beam radiation therapy and multicatheter brachytherapy), with similar acute and late toxicity. While the use of intraoperative breast irradiation remains under debate, new very accelerated partial breast irradiation (overall treatment time not exceeding 2 days) protocols emerged with encouraging results. Accelerated partial breast irradiation is warranted for extreme hypofractionated breast irradiation and is indicated for low-risk breast cancers. Moderate and extreme hypofractionated breast irradiation regimens are validated and can be routinely proposed according to patient selection criteria.  相似文献   
23.
Introduction: Collaborative interactions between several diverse biological processes govern the onset and progression of breast cancer. These processes include alterations in cellular metabolism, anti-tumor immune responses, DNA damage repair, proliferation, anti-apoptotic signals, autophagy, epithelial-mesenchymal transition, components of the non-coding genome or onco-mIRs, cancer stem cells and cellular invasiveness. The last two decades have revealed that each of these processes are also directly regulated by a component of the cell cycle apparatus, cyclin D1.

Area covered: The current review is provided to update recent developments in the clinical application of cyclin/CDK inhibitors to breast cancer with a focus on the anti-tumor immune response.

Expert opinion: The cyclin D1 gene encodes the regulatory subunit of a proline-directed serine-threonine kinase that phosphorylates several substrates. CDKs possess phosphorylation site selectivity, with the phosphate-acceptor residue preceding a proline. Several important proteins are substrates including all three retinoblastoma proteins, NRF1, GCN5, and FOXM1. Over 280 cyclin D3/CDK6 substrates have b\een identified. Given the diversity of substrates for cyclin/CDKs, and the altered thresholds for substrate phosphorylation that occurs during the cell cycle, it is exciting that small molecular inhibitors targeting cyclin D/CDK activity have encouraging results in specific tumors.  相似文献   

24.
25.
26.
27.
28.
We report a case of benign lymphoplasmacytic plaque (LPP) in a child. These asymptomatic erythematous papulonodular lesions are an emerging clinicopathological entity. Herein, we describe a previously unreported site for LPP lesions, namely, the volar wrist and the distal ipsilateral palm.  相似文献   
29.
30.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号